Lee Ainslie - Maverick Capital Ltd
Holding/activity history for AbbVie Inc. (ABBV)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2023 Q4 | 0 | 0.00 | Sell 100.00% | 0.02 | SEC | ||
| 2023 Q3 | 6,073 | 0.02 | Buy | 0.02 | $149.06 | $905,241 | SEC |
| 2021 Q4 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2021 Q3 | 11,681 | 0.01 | Reduce 18.19% | <0.01 | $107.87 | $1,260,000 | SEC |
| 2021 Q2 | 14,279 | 0.02 | Buy | 0.02 | $112.61 | $1,608,000 | SEC |
| 2021 Q1 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2020 Q4 | 6,210 | 0.01 | Add 207.12% | <0.01 | $107.09 | $665,000 | SEC |
| 2020 Q3 | 2,022 | <0.01 | Buy | <0.01 | $87.54 | $177,000 | SEC |
| 2017 Q3 | 0 | 0.00 | Sell 100.00% | 0.05 | SEC | ||
| 2017 Q2 | 57,400 | 0.05 | Add 29.28% | 0.01 | $72.51 | $4,162,000 | SEC |
| 2017 Q1 | 44,400 | 0.04 | Reduce 12.80% | <0.01 | $65.16 | $2,893,000 | SEC |
| 2016 Q4 | 50,920 | 0.04 | Add 2.66% | <0.01 | $62.63 | $3,189,000 | SEC |
| 2016 Q3 | 49,600 | 0.04 | Reduce 1.86% | <0.01 | $63.06 | $3,128,000 | SEC |
| 2016 Q2 | 50,540 | 0.04 | Add 17.07% | <0.01 | $61.91 | $3,129,000 | SEC |
| 2016 Q1 | 43,170 | 0.04 | Buy | 0.04 | $57.12 | $2,466,000 | SEC |
| 2015 Q3 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2015 Q2 | 3,950 | <0.01 | Reduce 8.56% | <0.01 | $67.09 | $265,000 | SEC |
| 2015 Q1 | 4,320 | <0.01 | Buy | <0.01 | $58.56 | $253,000 | SEC |
| 2014 Q4 | 0 | 0.00 | Sell 100.00% | 4.57 | SEC | ||
| 2014 Q3 | 4,723,578 | 4.57 | Add 46.01% | 1.44 | $57.76 | $272,834,000 | SEC |
| 2014 Q2 | 3,235,133 | 3.05 | Buy | 3.05 | $56.44 | $182,591,000 | SEC |